يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"beta1a interferon/ae [Adverse Drug Reaction]"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    مورد إلكتروني

    مصطلحات الفهرس: electrocardiography, Expanded Disability Status Scale, heart atrium enlargement/di [Diagnosis], heart catheterization, heart right atrium pressure, histopathology, human, human tissue, hypertrophy, hypoxemia/th [Therapy], immunosuppressive treatment, long term care, lung diffusion capacity, lung transplantation, lung vascular resistance, lung wedge pressure, maximum tolerated dose, middle aged, multiple sclerosis/di [Diagnosis], multiple sclerosis/dt [Drug Therapy], New York Heart Association class, oxygen therapy, pulmonary hypertension/di [Diagnosis], pulmonary hypertension/dt [Drug Therapy], pulmonary hypertension/si [Side Effect], beta1a interferon/dt [Drug Therapy], bosentan/dt [Drug Therapy], diltiazem/dt [Drug Therapy], fingolimod/dt [Drug Therapy], hematoxylin, hydrochlorothiazide/dt [Drug Therapy], perindopril/dt [Drug Therapy], prostacyclin/dt [Drug Therapy], prostacyclin/iv [Intravenous Drug Administration], sildenafil/dt [Drug Therapy], sildenafil/iv [Intravenous Drug Administration], sitaxsentan/dt [Drug Therapy], sitaxsentan/iv [Intravenous Drug Administration], teriflunomide/dt [Drug Therapy], warfarin/dt [Drug Therapy], heart right atrium enlargement/di [Diagnosis], heart right ventricular systolic dysfunction/di [Diagnosis], female, risk factor, six minute walk test, thorax radiography, transthoracic echocardiography, treatment duration, ambrisentan/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], adult, article, cardiomegaly, case report, clinical article, drug substitution, drug tolerability, dyspnea, echocardiography, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39587Test
    Multiple Sclerosis Journal
    Click here for full text options
    LibKey Link

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: electrocardiography, Expanded Disability Status Scale, heart atrium enlargement/di [Diagnosis], heart catheterization, heart right atrium pressure, histopathology, human, human tissue, hypertrophy, hypoxemia/th [Therapy], immunosuppressive treatment, long term care, lung diffusion capacity, lung transplantation, lung vascular resistance, lung wedge pressure, maximum tolerated dose, middle aged, multiple sclerosis/di [Diagnosis], multiple sclerosis/dt [Drug Therapy], New York Heart Association class, oxygen therapy, pulmonary hypertension/di [Diagnosis], pulmonary hypertension/dt [Drug Therapy], pulmonary hypertension/si [Side Effect], beta1a interferon/dt [Drug Therapy], bosentan/dt [Drug Therapy], diltiazem/dt [Drug Therapy], fingolimod/dt [Drug Therapy], hematoxylin, hydrochlorothiazide/dt [Drug Therapy], perindopril/dt [Drug Therapy], prostacyclin/dt [Drug Therapy], prostacyclin/iv [Intravenous Drug Administration], sildenafil/dt [Drug Therapy], sildenafil/iv [Intravenous Drug Administration], sitaxsentan/dt [Drug Therapy], sitaxsentan/iv [Intravenous Drug Administration], teriflunomide/dt [Drug Therapy], warfarin/dt [Drug Therapy], heart right atrium enlargement/di [Diagnosis], heart right ventricular systolic dysfunction/di [Diagnosis], female, risk factor, six minute walk test, thorax radiography, transthoracic echocardiography, treatment duration, ambrisentan/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], adult, article, cardiomegaly, case report, clinical article, drug substitution, drug tolerability, dyspnea, echocardiography, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39587Test
    Multiple Sclerosis Journal
    Click here for full text options
    LibKey Link